Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - BIOLIFE SOLUTIONS INCex_235717.htm
EX-31.2 - EXHIBIT 31.2 - BIOLIFE SOLUTIONS INCex_235715.htm
EX-31.1 - EXHIBIT 31.1 - BIOLIFE SOLUTIONS INCex_235714.htm
EX-23.1 - EXHIBIT 23.1 - BIOLIFE SOLUTIONS INCex_235713.htm
EX-21.1 - EXHIBIT 21.1 - BIOLIFE SOLUTIONS INCex_238352.htm
EX-10.25 - EXHIBIT 10.25 - BIOLIFE SOLUTIONS INCex_238351.htm
EX-10.24 - EXHIBIT 10.24 - BIOLIFE SOLUTIONS INCex_238350.htm
EX-10.18 - EXHIBIT 10.18 - BIOLIFE SOLUTIONS INCex_238349.htm
EX-10.17 - EXHIBIT 10.17 - BIOLIFE SOLUTIONS INCex_238348.htm
EX-10.13 - EXHIBIT 10.13 - BIOLIFE SOLUTIONS INCex_238347.htm
EX-10.12 - EXHIBIT 10.12 - BIOLIFE SOLUTIONS INCex_238346.htm
EX-10.11 - EXHIBIT 10.11 - BIOLIFE SOLUTIONS INCex_238345.htm
EX-10.2 - EXHIBIT 10.2 - BIOLIFE SOLUTIONS INCex_238344.htm
10-K - FORM 10-K - BIOLIFE SOLUTIONS INCbioli20201231_10k.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of BioLife Solutions, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Rice, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

1.  

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

2.  

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated:  March 31, 2021

 

/s/ Michael Rice

 

Michael Rice

 

Chief Executive Officer